Wendy S. Johnson - Jul 14, 2021 Form 4 Insider Report for Reneo Pharmaceuticals, Inc. (RPHM)

Signature
/s/ Vineet R. Jindal, Attorney-in-Fact
Stock symbol
RPHM
Transactions as of
Jul 14, 2021
Transactions value $
-$949,756
Form type
4
Date filed
7/15/2021, 05:33 PM
Previous filing
Jul 9, 2021
Next filing
Sep 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPHM Common Stock Sale -$950K -112K -100% $8.50 0 Jul 14, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person previously notified the Issuer of her intention to retire from her position as the Issuer's Chief Development Officer, effective on or before December 31, 2021. Following her announcement, the Reporting Person exercised an option totaling 111,736 shares of Common Stock of the Issuer (the "Shares") on July 8, 2021. The Reporting Person is selling the Shares privately to Abingworth Bioventures 8 LP ("Abingworth"), an existing stockholder of the Issuer. Bali Muralidhar, a Director of the Issuer, is a member of the investment committee of Abingworth.